{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:25:22Z","timestamp":1777317922676,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.msard.2024.105883","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T14:22:29Z","timestamp":1725805349000},"page":"105883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The effects of the MTHFR 677C>T (rs1801133) genetic variant on susceptibility and disability worsening in multiple sclerosis patients are mediated by homocysteine"],"prefix":"10.1016","volume":"91","author":[{"given":"Claudia Mara","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayonara Rangel","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamires","family":"Flauzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Frizon","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Name Colado","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcell Alysson Batisti","family":"Lozovoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-2839","authenticated-orcid":false,"given":"Edna Maria Vissoci","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2024.105883_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12031-010-9486-y","article-title":"Inflammatory profile, age of onset, and the MTHFR polymorphism in patients with multiple sclerosis","volume":"44","author":"Alatab","year":"2011","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.msard.2024.105883_bib0002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","article-title":"Vitamin D and multiple sclerosis","volume":"9","author":"Ascherio","year":"2010","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105883_bib0003","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/01616412.2024.2337519","article-title":"Genetic variants of folate metabolism and the risk of multiple sclerosis","volume":"46","author":"A\u015fc\u0131","year":"2024","journal-title":"Neurolog. Res."},{"issue":"1","key":"10.1016\/j.msard.2024.105883_bib0004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Royal Statist. Soc.. Ser. B (Methodol.)"},{"issue":"9","key":"10.1016\/j.msard.2024.105883_bib0005","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.msard.2024.105883_bib0006","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis","volume":"98","author":"Brattstr\u00f6m","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.msard.2024.105883_bib0007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5114\/fn.2019.83829","article-title":"Relationship between genetic polymorphisms MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes and multiple sclerosis: a case-control study","volume":"57","author":"Cakina","year":"2019","journal-title":"Folia Neuropathol."},{"issue":"8","key":"10.1016\/j.msard.2024.105883_bib0008","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/JIM.0000000000000107","article-title":"Association of methylenetetrahydrofolate reductase gene C677T polymorphism with multiple sclerosis in Turkish patients","volume":"62","author":"Cevik","year":"2014","journal-title":"J. Investig. Med."},{"issue":"4","key":"10.1016\/j.msard.2024.105883_bib0009","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/ndt\/gfi254","article-title":"Vitamin D decreases NFkappaB activity by increasing I kappa B alpha levels","volume":"21","author":"Cohen-Lahav","year":"2006","journal-title":"Nephrol. Dial. TransPlant"},{"issue":"2","key":"10.1016\/j.msard.2024.105883_bib0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3892\/mmr.2020.11204","article-title":"Downregulation of folate receptor \u03b1 contributes to homocysteineinduced human umbilical vein endothelial cell injury via activation of endoplasmic reticulum stress","volume":"22","author":"Cui","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.msard.2024.105883_bib0011","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.msard.2017.08.004","article-title":"Vitamin B12, folate, and homocysteine levels and multiple sclerosis: a meta-analysis","volume":"17","author":"Dardiotis","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"410","key":"10.1016\/j.msard.2024.105883_bib0012","article-title":"Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: a follow-up study","volume":"15","author":"de Carvalho Jennings Pereira","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.msard.2024.105883_bib0013","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archneur.57.10.1422","article-title":"Homocysteine and neurologic disease","volume":"57","author":"Diaz-Arrastia","year":"2000","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2024.105883_bib66","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/brainsci10090637","article-title":"Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis","volume":"10","author":"Dubchenko","year":"2002","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.105883_bib0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12974-021-02073-7","article-title":"Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis","volume":"18","author":"Elo","year":"2021","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2024.105883_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.STR.0000115161.10646.67","article-title":"Hiperhomocysteinemia, oxidative stress and cerebral vascular dysfunction","volume":"35","author":"Faraci","year":"2004","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.msard.2024.105883_bib0016","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.clineuro.2013.02.025","article-title":"Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients","volume":"115","author":"Fekih-Mrissa","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105883_bib0017","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0037-1614230","article-title":"Analysis of the 677 CT mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups","volume":"79","author":"Franco","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.msard.2024.105883_bib0018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate gene risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.msard.2024.105883_bib0019","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s003359900838","article-title":"Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)","volume":"9","author":"Goyette","year":"1998","journal-title":"Mamm. Genome"},{"issue":"5","key":"10.1016\/j.msard.2024.105883_bib65","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","article-title":"Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage","volume":"70","author":"Ho","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2024.105883_bib0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9343(01)00696-9","article-title":"Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects","volume":"110","author":"Holven","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.msard.2024.105883_bib69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2004.11.007","article-title":"Cytokines in multiple sclerosis: from bench to bedside","volume":"106","author":"Imitola","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.msard.2024.105883_bib0022","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3892\/mmr.2013.1256","article-title":"Cytokine profile in relapsingremitting multiple sclerosis patients and the association between progression and activity of the disease","volume":"7","author":"Kallaur","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.msard.2024.105883_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12035-015-9648-6","article-title":"Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.msard.2024.105883_bib0024","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaut.2014.01.022","article-title":"The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review","volume":"48-49","author":"Karussis","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2024.105883_bib0025","first-page":"227","article-title":"Genetic polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) in healthy Koreans","volume":"24","author":"Kim","year":"2002","journal-title":"Korean J. Genet"},{"issue":"3","key":"10.1016\/j.msard.2024.105883_bib0026","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2009.10.057","article-title":"The variant methylenetetrahydrofolate reductase c.1298A[C (p. E429A) is associated with multiple sclerosis in a German case-control study","volume":"468","author":"Klotz","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.msard.2024.105883_bib0027","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jocn.2008.05.015","article-title":"Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis","volume":"16","author":"Kocer","year":"2009","journal-title":"J. Clin. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.msard.2024.105883_bib0028","first-page":"46","article-title":"Serum NSE level and disability progression in multiple sclerosis","volume":"350","author":"Koch","year":"2005","journal-title":"J. Neurol. Sci. Mar."},{"issue":"18","key":"10.1016\/j.msard.2024.105883_bib0029","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.msard.2024.105883_bib0030","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105883_bib0031","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajp.2012.03.002","article-title":"Association between MTHFR C677T and A1298C, and MTRR A66G polymorphisms and susceptibility to schizophrenia in a Syrian study cohort","volume":"5","author":"Lajin","year":"2012","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.msard.2024.105883_bib0032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5114\/fn.2018.80863","article-title":"Correlations between plasma homocysteine and MTHFR gene polymorphism and white matter lesions","volume":"56","author":"Li","year":"2008","journal-title":"Folia Neuropathol."},{"issue":"6","key":"10.1016\/j.msard.2024.105883_bib0033","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7150\/ijms.42058","article-title":"Serum levels of homocysteine, vitamin b12 and folate in patients with multiple sclerosis: an updated meta-analysis","volume":"17","author":"Li","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.msard.2024.105883_bib0034","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.3390\/nu7085303","article-title":"Homocysteine metabolism gene polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) jointly elevate the risk of folate deficiency","volume":"7","author":"Li","year":"2015","journal-title":"Nutrients."},{"key":"10.1016\/j.msard.2024.105883_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4568145","article-title":"Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of autoimmune diseases: a systematic review and meta-analysis","volume":"2022","author":"Lu","year":"2022","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.msard.2024.105883_bib0036","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.3390\/ijerph110606417","article-title":"Environmental factors and multiple sclerosis severity: a descriptive study","volume":"11","author":"Mandia","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.msard.2024.105883_bib0037","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends. Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2024.105883_bib0038","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s12035-019-01856-7","article-title":"Antioxidant and anti-inflammatory diagnostic biomarkers in multiple sclerosis: a machine learning study","volume":"57","author":"Mezzaroba","year":"2020","journal-title":"Mol Neurobiol."},{"issue":"9","key":"10.1016\/j.msard.2024.105883_bib0039","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.clineuro.2013.05.007","article-title":"Homocysteine, vitamin B12 and folate levels in Iranian patients with multiple sclerosis: a case control study","volume":"115","author":"Moghaddasi","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.msard.2024.105883_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000317393","article-title":"Serum adiponectin, TNF-\u03b1, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens","volume":"18","author":"Musabak","year":"2011","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1016\/j.msard.2024.105883_bib0041","first-page":"87","article-title":"Association between MTHFR genetic variants and multiple sclerosis in a southern Iranian population","author":"Naghibalhossaini","year":"2015","journal-title":"Int. J. Mol. Cell Med."},{"issue":"Suppl. 1","key":"10.1016\/j.msard.2024.105883_bib0042","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0049-3848(01)00295-X","article-title":"Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease","volume":"103","author":"Nikfardjam","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/j.msard.2024.105883_bib0043","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.msard.2024.105883_bib0044","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-5728(00)00444-6","article-title":"Multiple sclerosis: genomic rewards","volume":"113","author":"Oksenberg","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2024.105883_bib0045","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11011-018-0224-4","article-title":"Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis","volume":"33","author":"Oliveira","year":"2018","journal-title":"Metab Brain Disease"},{"key":"10.1016\/j.msard.2024.105883_bib0046","first-page":"213","article-title":"Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress","volume":"381","author":"Oliveira","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105883_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101395","article-title":"Homocysteine, vitamin B12, and folate levels in patients with multiple sclerosis in Chinese population: a case-control study and meta-analysis","volume":"36","author":"Pan","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2024.105883_bib0048","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105883_bib0049","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2005.072199","article-title":"Plasma homocysteine levels in multiple sclerosis","volume":"77","author":"Ramsaransing","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.msard.2024.105883_bib0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2024.105883_bib0051","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00011-019-01286-0","article-title":"Tumor necrosis factor alpha (TNF-\u03b1) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis","volume":"68","author":"Ribeiro","year":"2019","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.msard.2024.105883_bib0052","series-title":"SmartPLS 3","author":"Ringle","year":"2005"},{"key":"10.1016\/j.msard.2024.105883_bib0053","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.msard.2024.105883_bib0054","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/1352458506075503","article-title":"Increased plasma homocysteine levels in multiple sclerosis","volume":"13","author":"Sahin","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105883_bib0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2006-9404","article-title":"Elevated plasma homocysteine levels: risk factors or risk marker for the development of dementia and Alzheimer \u2018s disease?","volume":"9","author":"Seshadri","year":"2006","journal-title":"J. Alzheimer Dis"},{"issue":"3","key":"10.1016\/j.msard.2024.105883_bib0056","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainresbull.2006.01.005","article-title":"Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis","volume":"69","author":"Tajouri","year":"2006","journal-title":"Brain Res. Bull."},{"issue":"12","key":"10.1016\/j.msard.2024.105883_bib64","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2008.151555","article-title":"Serum homocysteine levels in relation to clinical progression in multiple sclerosis","volume":"79","author":"Teunissen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.msard.2024.105883_bib0057","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1744-859X-7-17","article-title":"Increased plasma homocysteine levels in patients with multiple sclerosis and depression","volume":"7","author":"Triantafyllou","year":"2008","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.msard.2024.105883_bib0058","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-6147(00)01675-8","article-title":"Biological and clinical implications of the MTHFR C677T polymorphism","volume":"22","author":"Ueland","year":"2001","journal-title":"Trends. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2024.105883_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1191\/1352458503ms918oa","article-title":"Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid","volume":"9","author":"Vrethem","year":"2003","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2024.105883_bib0059","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190460","article-title":"Pathogenic T cell cytokines in multiple sclerosis","volume":"217","author":"Wagner","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2024.105883_bib0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","article-title":"A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity","volume":"64","author":"Weisberg","year":"1998","journal-title":"Mol Gen Metab"},{"issue":"2","key":"10.1016\/j.msard.2024.105883_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600351","article-title":"Influence of food groups on plasma total homocysteine for specific MTHFR C677T genotypes in Chinese population","volume":"61","author":"Zeng","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"issue":"7","key":"10.1016\/j.msard.2024.105883_bib0062","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1007\/s12035-016-0036-7","article-title":"Adiponectin suppresses T helper 17 cell differentiation and limits autoimmune CNS inflammation via the SIRT1\/PPAR\u03b3\/ROR\u03b3t pathway","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.msard.2024.105883_bib0063","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jocn.2010.12.022","article-title":"Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis","volume":"18","author":"Zhu","year":"2011","journal-title":"J. Clin. Neurosci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:30:38Z","timestamp":1732336238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824004590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":67,"alternative-id":["S2211034824004590"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105883","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of the MTHFR 677C>T (rs1801133) genetic variant on susceptibility and disability worsening in multiple sclerosis patients are mediated by homocysteine","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105883"}}